This report, launched on April 16, 2019, provides an in-depth analysis of bullous pemphigoid, including epidemiology, treatment patterns, and market opportunities from 2017-2028. It covers patient demographics, current treatment practices, unmet needs, and a detailed pipeline analysis of upcoming therapies. With geography coverage across major markets and various licensing options, the report is aimed at aiding business strategy development and understanding market dynamics.